[eDisclosure Notice] KOSDAQ -30 Days
▲Sejung=Announced that with the reappointment of CEO Cheon Ho-jeon, the company has changed to a co-CEO system with Cheon Se-jeon, Kim Ki-baek, and Cheon Ho-jeon serving as individual CEOs.
▲Hanchang Biotech=Announced a name change to Exergy21. Also appointed new CEOs Lee Yong-eung and Shim Hong-gi.
▲Yeon E B&T=Announced the resumption of the orderly liquidation process following the dismissal of the injunction request against the delisting decision.
▲Yulho=Announced a decision to acquire convertible bonds from Paratech worth 10 billion KRW. Stated that they will engage in management if necessary to generate profits through business cooperation.
Hot Picks Today
"Parents Deposited 10 Million Won for Me"... Se...
- DL E&C Granted Injunction Suspending Termination of Sangdaewon District 2 Contra...
- "SK Hynix Stock Windfall"... Teenager With Wads of Cash Turns Thief at Jewelry S...
- "Major Crash Is Coming... Buy Even If You Have to Skip a Meal" 'Rich Dad' Shares...
- "Save 30 Million Won, Grow It to 100 Million": Dramatic Pledge Sparks "Is This a...
▲Crystal Genomics=Announced the submission of a multi-center clinical trial plan approval application to the Ministry of Food and Drug Safety for the combination therapy of the anti-PD-1 antibody camrelizumab (SHR-1210) with Pemetrexed and Carboplatin as a first-line treatment for non-small cell lung cancer patients.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
